Free Trial
NASDAQ:GCTK

GlucoTrack (GCTK) Stock Price, News & Analysis

GlucoTrack logo
$6.80 +0.28 (+4.21%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$6.70 -0.11 (-1.54%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About GlucoTrack Stock (NASDAQ:GCTK)

Key Stats

Today's Range
$6.30
$7.38
50-Day Range
$5.22
$11.06
52-Week Range
$5.16
$3,756.00
Volume
249,488 shs
Average Volume
170,059 shs
Market Capitalization
$3.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GlucoTrack Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

GCTK MarketRank™: 

GlucoTrack scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for GlucoTrack.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GlucoTrack is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GlucoTrack is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    4.37% of the float of GlucoTrack has been sold short.
  • Short Interest Ratio / Days to Cover

    GlucoTrack has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GlucoTrack has recently decreased by 95.89%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    GlucoTrack does not currently pay a dividend.

  • Dividend Growth

    GlucoTrack does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.37% of the float of GlucoTrack has been sold short.
  • Short Interest Ratio / Days to Cover

    GlucoTrack has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GlucoTrack has recently decreased by 95.89%, indicating that investor sentiment is improving significantly.
  • Search Interest

    4 people have searched for GCTK on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added GlucoTrack to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GlucoTrack insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.91% of the stock of GlucoTrack is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 10.92% of the stock of GlucoTrack is held by institutions.

  • Read more about GlucoTrack's insider trading history.
Receive GCTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter.

GCTK Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
GlucoTrack Inc trading resumes
See More Headlines

GCTK Stock Analysis - Frequently Asked Questions

GlucoTrack's stock was trading at $447.60 on January 1st, 2025. Since then, GCTK stock has decreased by 98.5% and is now trading at $6.8050.

GlucoTrack, Inc. (NASDAQ:GCTK) posted its quarterly earnings results on Wednesday, May, 14th. The company reported ($20.40) earnings per share for the quarter.

Shares of GlucoTrack reverse split on Tuesday, February 4th 2025.The 1-20 reverse split was announced on Thursday, January 30th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 3rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of GCTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GlucoTrack investors own include Rolls-Royce Holdings PLC (RYCEY), Blink Charging (BLNK), Cameco (CCJ), Cybin (CYBN), Cyclo Therapeutics (CYTH), Ford Motor (F) and iShares U.S. Infrastructure ETF (IFRA).

Company Calendar

Last Earnings
5/14/2025
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:GCTK
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.60 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($983.43) per share
Price / Book
-0.01

Miscellaneous

Free Float
416,000
Market Cap
$3.27 million
Optionable
Not Optionable
Beta
-0.24
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:GCTK) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners